Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
A Phase II Trial of Perioperative CV301 Vaccination in Combination with Nivolumab and and Systemic Chemotherapy for Resectable Hepatic-Limited Metastatic Colorectal Cancer
A Phase III, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer